RATify - Radiology AI Assurance Testing platform

基于人工智能的医疗保健应用程序(AI)可能会对全球医疗保健系统的现代化产生重大影响，放射学被视为最有前途的领域之一，临床人工智能为不断增长的成像测试需求和持续的劳动力危机(BMC Health Services Research 2021)提供了潜在的解决方案。然而，随着人工智能应用扩展到放射学，人们越来越担心人工智能算法需要接受质量保证审查，类似于成像系统，以确保它们对患者安全有效，按预期执行并产生准确的数据。虽然内部验证是法规遵从性(MHRA)所必需的，但目前还没有标准的行业路径来验证部署后的人工智能医学成像解决方案。然而，人工智能医疗技术的监管格局正在迅速变化，特别是在英国，NICE ESF数字医疗技术2022更新需要展示在英国医疗和社会护理系统中的价值。设想其新的AI验证平台APPEL是第一个执行NICE 2022更新中指定的关于分类、对象检测和分割AI模型的回顾和前瞻性人工智能研究的平台。供应商无关的AI验证平台为组织在其环境中选择、部署和监控AI解决方案提供全面的AI保证，并为放射科医生提供无缝的工作流以进行实时审计和监控。该工具还将与人工智能采用生命周期中更广泛的利益相关者相关，包括人工智能开发人员、服务提供商和研究人员。批准的成功商业化将巩固我们的全球扩展雄心，同时也增强信心并将人工智能技术实施到放射学中，并解决全球对临床治理的需求，特别是与NHS相关的需求。

AI-based healthcare applications (AI) could potentially have a significant impact on modernising health care systems globally, with radiology seen as one of the most promising fields where clinical AI offers a potential solution to the increasing demand for imaging tests and the ongoing workforce crisis (BMC HEalth SErvices Research 2021).However, as AI adoption expands into radiology, there is growing concern that AI algorithms need to undergo quality assurance reviews, similar to imaging systems, to ensure they are safe and effective for patients, performing as intended and producing accurate data.Whilst internal validation is required for regulatory compliance (MHRA) there are currently no standard industry pathways to validate AI medical imaging solutions once deployed. However the regulation landscape for AI med-tech is changing rapidly, particularly in the UK with the NICE ESF digital health technologies 2022 update requiring demonstration of value in the UK health and social care system.Envisionit's new AI validation platform, RATify, is the first to perform both retrospective and prospective AI studies on classification, object detection and segmentation AI models, as specified in the NICE 2022 updates.The vendor agnostic AI Validation platform provides holistic AI assurance for organisations when selecting, deploying and monitoring AI solutions in their environment and a seamless workflow for radiologists for real-time audit and monitoring. The tool will also be relevant to wider stakeholders in the AI adoption life cycle including AI developers, service providers and researchers.The successful commercialisation of RATify will underpin our global scaling ambitions, whilst also boosting confidence and implementation of AI technologies into radiology and solving a global need for clinical governance, specifically relevant for the NHS.